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Summary The progress of retinal imaging techniques has made retinal microvascular circu-
lation easier to study. A number of observational studies were conducted to characterise the
different abnormalities encountered and to determine the factors contributing to their onset.
Three lesion groups were highlighted, including reduced arteriolar diameter, venular dilata-
tion and retinopathy lesions. Retinal arteriolar narrowing signals the presence of hypertension
(current or old) and the risk of hypertension onset. A genetic factor was implicated in this rela-
tionship. Venular dilatation and retinopathy correlate with the presence of diabetes, obesity
and metabolic disorders. This association appears to be mediated partly by the presence of
endothelial dysfunction and inﬂammation. The relationship between these abnormalities and
cardiovascular risk was also studied in a number of longitudinal studies: the presence of retinal
microvascular abnormalities is related with an increased risk of cardiovascular morbidity and
mortality predominantly in individuals under the age of 75. More speciﬁcally, retinopathy is
correlated with the presence of cerebral white matter lesions detected by MRI, an increased
stroke risk and deterioration in cognitive function. On the cardiovascular level, a correlation was
demonstrated between diminished coronary reserve, increased coronary calciﬁcations observed
by CT scan, coronary morbidity and mortality, and risk of heart failure. New techniques of reti-
nal imaging, such as laser Doppler ﬂowmetry, are still undergoing assessment and will help
elations.further to clarify these corr
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Résumé La microvascularisation rétinienne grâce au progrès des techniques d’imagerie
rétinienne, peut être facilement étudiée. De nombreuses études observationnelles ont été
réalisées aﬁn de caractériser les différentes anomalies retrouvées et déterminer les facteurs
favorisant leur apparition. Trois groupes de lésions sont mis en evidence : réduction du diamètre
artériolaire, dilatation veineuse et lésions de rétinopathie. La diminution du diamètre artéri-
olaire signe la présence d’HTA (actuelle ou ancienne) mais également le risque de survenue
d’HTA. Il a été montré l’implication d’un facteur génétique dans cette relation. La dilata-
tion veineuse et la rétinopathie sont, elles, corrélées à la présence de diabète, d’obésité, de
syndrome métabolique. Cette association semble être médiée en partie par la présence de
dysfonction endothéliale et d’inﬂammation. La relation entre ces anomalies et le risque car-
diovasculaire a également été étudiée dans de nombreuses études longitudinales : la présence
d’anomalies de la microvascularisation rétinienne est corrélée, de fac¸on prédominante chez
les personnes de moins de 75 ans, à une augmentation du risque de morbimortalité cardio-
vasculaire. De manière plus spéciﬁque, au niveau cérébral, la rétinopathie est corrélée avec :
la présence d’anomalies de la substance blanche à l’IRM, une augmentation du risque d’AVC
et de détérioration des fonctions cognitives. Au niveau cardiovasculaire, il a été montré une
corrélation avec une diminution de la réserve coronaire, une augmentation des calciﬁcations
coronaires au scanner, de morbimortalité coronarienne et d’insufﬁsance cardiaque. De nou-
velles techniques comme la ﬂuxmétrie à laser Doppler sont en cours d’évaluation et permettront
peut-être de mieux préciser ces corrélations.
© 2009 Elsevier Masson SAS. Tous droits réservés.
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abbreviations
VR arteriole to venule ratio
D venular dilatation
Vnicking arteriovenous nicking
AN focal arteriolar narrowing
AN generalised arteriolar narrowing
HD coronary heart disease
VH left ventricular hypertrophy
HF cardiac heart failure
Retinal microvascularisation, easily accessible with non-
nvasive procedures, appears to share the same physiological
nd anatomical characteristics as cerebral and coro-
ary microvascularisation [1]. Retinal microvascularisation
bnormalities could therefore reﬂect those observed in
erebral and coronary microvascularisation. Progress in
omputerised retinal photographic techniques [2—4] has
nabled more accurate and reproducible analyses of reti-
al microvascularisation. A number of studies involving
arge population samples have therefore been conducted
o try and understand which factors contribute to develop-
ng retinal microangiopathy, and its link with the onset of a
ardiovascular event.
ackground
y the end of the 19th century, Marcus Gun had described the
orrelation between retinal microvascular signs and hyper-
ension, nephropathies and cerebrovascular diseases [5—7].
n 1939, Keith, Wagener, and Baker established the progno-
is value of hypertensive retinopathy, speciﬁcally three-year
urvival at grade I (mild to moderate retinal arteriolar nar-
r
M
a
powing) was estimated to be 70% while that at grade IV
papillary oedema) was 6% [8]. As the arterioles could not be
isualised in peripheral organs, the authors concluded that
he retina offered a singular opportunity to study microcir-
ulation in clinical practice.
The clinical interest in retinopathy, however, has
emained limited. The correlation between these abnor-
alities and the cardiovascular disease was never clearly
emonstrated in all the studies due to a number
f biases, including the presence of confounding fac-
ors like hypertension, the lack of a control group,
he lack of clinical outcomes, a studied population
ith severe uncontrolled hypertension that was not
epresentative of the general population, and an oph-
halmoscopic examination technique subjective and non-
eproducible.
New techniques have allowed for the quantiﬁcation of
etinal vascularisation characteristics in a more objective
nd reproducible way. Thus, new data has emerged in an
ttempt to characterise the prevalence and incidence of
hese changes in retinal microcirculation, their relationship
ith cerebral and coronary microangiopathy and macroan-
iopathy, and therefore the role of retinal microcirculation
s a risk marker of cardiovascular morbidity and mortal-
ty (since the cause and effect relationships have yet to be
stablished).
ifferent retinal microcirculation signs
nd their relationship with cardiovascular
isk factors
ost current studies use high-resolution retinal photographs
nalysed according to standardised protocols and using com-
uter assisted method [9,10,2].
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fFigure 1. Retinopathy associating microaneurysms, retinal haem-
orrhages and cotton-wool spots.
Retinopathy
Retinopathy screening (considered present if one of these
lesions exist: microaneurysm, haemorrhage, cotton wool
spots, hard exudate, venular beading, neovessel formation)
has a reproducibility of 0.80 to 0.99 (Fig. 1). These abnor-
malities are common during diabetes, but the earliest stages
of some (retinal haemorrhages, microaneurysms and cot-
ton wool spots) can be observed outside of diabetes. More
recent studies have shown the prevalence of these lesions
Figure 2. Arterio-venous nicking — the rigid arteriole compresses
the vein as they cross within a common adventitial sheath.
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rigure 3. Focal arteriolar narrowing.
n 9% to 10% of the general population over the age of
2.
The three main factors behind its onset and develop-
ent in diabetic patients are the duration of diabetes,
he quality of glycemic and blood pressure control. The
pidemiologic study of a diabetic cohort (the Wisconsin Epi-
emiologic Study of Diabetic Retinopathy WESDR) reported
retinopathy prevalence of 25% in patients with type 1 dia-
etes for ﬁve years and 80% in patients with type 1 diabetes
or more than 15 years [11]. The importance of the hyper-
lycemia was demonstrated in epidemiologic studies and in
he DDCT [12] and UKPDS studies [13]. The UKPDS study also
emonstrated that strict blood pressure control reduced the
ikely development of retinopathy independently of hyper-
lycemia [13]. New data suggest that lipid-lowering therapy
ould also decrease the use of laser treatment [14].
igure 4. Semi-automatic measurement of the arteriole to venule
atio according to the Hubbard method.
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Table 1 Description of different longitudinal studies.
Studies Acronym Number of
participants
Age at
study start
Description
Atherosclerosis Risk In
Communities study
ARIC 15792 45—64 Longitudinal prospective study
of cardiovascular diseases in
four American communities
Beaver Dam Eye Study BDES 4926 43—84 Longitudinal prospective study
concerning ophthalmologic
diseases and public health in an
American population
Cardiovascular Health study CVHS 5201 > 65 Longitudinal prospective study
of cardiovascular diseases in an
older, American population
Rotterdam Study Rott 7983 > 55 Longitudinal prospective study
of chronic diseases in a Dutch
population
Blue Montains Eyes Study BMES 3654 > 49 Longitudinal prospective study
concerning ophthalmologic
diseases and public health in an
Australian population
The Multi-Ethnic Study of MESA 6814 45—84 Longitudinal prospective study
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Apart from diabetes, hypertension is also a signiﬁcant
isk factor in the onset of these retinal abnormalities. They
re more often associated with AVnicking, and arterio-
ar abnormalities (retinal arteriolar narrowing and copper
ppearance of the arteriolar wall). The different prospec-
ive cohort studies also demonstrated a correlation between
etinopathy and body mass index, age, African-American
rigin [15—17], and more controversially, an increase in
brinogen and triglycerides [15,17]. In the Cardiovascular
ealth study, retinopathy was associated with the presence
f infraclinical atherosclerosis markers like carotid plaque
nd increased intimal medial thickness of the carotid artery
18].
The signiﬁcance of its presence in normotensive patients
ithout diabetes is still poorly deﬁned. Its prevalence here
s 2.6% to 8.6% [19]. Its role in predicting the onset of dia-
etes is controversial. Indeed, while it is associated with an
ncreased risk in diabetes onset in young people and those
ith a family history of diabetes [20] in 2 epidemiologic stud-
es, other prospective studies (Blue Mountains Study [21] and
eaver Dam [22]) have not conﬁrmed this association [23].
The relationship between retinopathy and obesity is not
lear. However, it appears that obesity increases the risk of
eveloping retinopathy in patients with type 1 [12] and type
[13] diabetes.
rteriolar and venular abnormalities
ocal arteriolar abnormalities include a FAN and the AVnick-
ng (Figs. 2 and 3). These signs are less reproducible (0.4 to
.7) [24,25]. They correlate with age and hypertension [10].
The measurement of the retinal vascular caliber has
ong been assessed using a ratio (arteriolar diameter over
enular diameter, AVR). Since the diameter of veinules
as then considered stable, a decreased ratio was there-
i
h
i
sconcerning atherosclerosis in an
American population
ore considered equivalent to arteriolar narrowing. The
mergence of a semi-computerised method using soft-
are (Fig. 4) enabled the obtaining of more accurate and
eproducible measurements of arteriolar and venular diam-
ters (inter- and intra-technician reproducibility reaching
.78 to 0.99) [3,26,27]. It was then demonstrated that a
ecreased AVR could also be secondary to an increased
enular diameter [28,29]. The change in arteriolar and venu-
ar diameter reﬂects different physiopathological processes
Tables 1 and 2).
Arteriolar narrowing is considered as a sign of hyperten-
ion, of a history of hypertension in the last three to six years
10] or even as a risk factor for the onset of hypertension in
ormotensive individuals [30—33]. Four prospective studies
ith large population samples, namely the Atherosclerosis
isk In Communities (ARIC) study [30], Beaver Dam Study
31], Blue Mountains Eyes Study [32] and Rotterdam Study
33] (the ﬁrst two using the AVR and the other two using
he arteriolar diameter) demonstrated that the presence of
decreased arteriolar diameter is a risk factor, regardless
f other factors, for developing hypertension within three
o 10 years in normotensive individuals. These observations
herefore strengthen the hypothesis that increased periph-
ral resistance, reﬂected by the narrowing of the arteriolar
iameter, could be one of the factors contributing to the
nset of hypertension [33]. Similarly, the Beaver Dam Study
onﬁrmed this hypothesis by demonstrating that there was a
enetic contribution in determining retinal vessel diameters
nd multiple genome regions related to the blood pressure
egulation system, endothelial function and angiogenesis are
nvolved [34].
Concerning the increased retinal venular diameter, it
as not been proven to be linked with hypertension. Still,
t does correlate with the presence of diabetes, obe-
ity, metabolic disorders, smoking, diagnostic inﬂammatory
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Table 2 Results of different longitudinal studies.
Studies Size of
study (n=)
Retinal lesions Outcome Result Number of events
Cardiac
MESA [46] 4593 GAN Concentric LVH Yes
ARIC [17] 11612 Retinopathy Hospitalisation or
death due to
cardiac
insufﬁciency
Yes, even in the
sub-group without
hypertension or
diabetes or heart
disease
492 in 7 years
Coronary
heart disease
MESA [51] 6147 Retinopathy Increased
coronary calcium
score
Yes
GAN Decreased
coronary reserve
Yes
CVHS [56] 1992 GAN, VD Incidence of CHD Yes 115 in 5 years
BMES [53] 3654 AVR, GAN Mortality
secondary to CHD
Only in the youngest
sub-group of women
aged 49—75 years
192 in 9 years
VD Mortality
secondary to CHD
Only in the youngest
sub-group of 49—75
years
BMES + BDES [54] 7494 GAN, VD Mortality due to
CHD
Only in the youngest
sub-group of 43—69
years
653 in 10.9 years
ARIC [55] 9648 AVR Mortality due to
CHD
Only in the
sub-group of women
271 in 3.5 years
Cerebral
ARIC [50] 1684 Retinopathy, FAN,
stroke, AV nicking
AVR
Cerebral
infarction
observed by MRI
Yes 183
CVHS [18] 1717 AVR, AV nicking Cerebral
infarction
observed by MRI,
white matter
lesions
Yes 496
ARIC [16] 1684 Retinopathy White matter
lesions observed
by MRI
Yes 186
Retinopathy, FAN, AV
nicking
Stroke Yes 32 in 4.7 years
CVHS [56] 1992 VD Stroke Yes 113 in 5 years
GAN Stroke No
ROTT [49] 5540 VD Stroke Yes 411 in 8.5 years
GAN Stroke No
ARIC [48] 10358 Retinopathy Stroke Yes 110 in 3.5 years
AVR Stroke No
BMES [15] 3654 Retinopathy Cerebrovascular
events
Only in the
sub-group without
diabetes
132 in 7 years
GAN, FAN, AV nicking Cerebrovascular
events
No
BMES + BDES [54] 7494 GAN, VD Cerebrovascular
mortality
No 299 in 10.9 years
AVR: arteriole to venule ratio; VD: venous dilatation; AV nicking: arteriovenous nicking; FAN: focal arteriolar narrowing; GAN: generalised
arteriolar narrowing; CHD: coronary heart disease.
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arkers, endothelial dysfunction and atherosclerosis mark-
rs (carotid plaque, intimal medial thickness and aortic
alciﬁcation) [10,35,36]. Venular dilatation appears to be
aused by the presence of retinal hypoxia [37].
In the population-based Blues Mountains Eye Study, the
resence of retinal VD was associated with obesity and the
nset of obesity at ﬁve years or a signiﬁcant weight gain [38].
his association may be explained in several ways. The pres-
nce of a chronic inﬂammatory syndrome and endothelial
ysfunction was described in obese individuals, particu-
arly when there was also a metabolic disorder and insulin
esistance [39,40]. In addition, the same correlation was
urther established between wider retinal venules [35,41]
nd the presence of a chronic inﬂammatory syndrome and
ndothelial dysfunction. Moreover, increased blood volume
nd leptin levels were noted in obese individuals, which
ould modify retinal vessel calibre via nitric oxide [42].
Hypertension and diabetes are correlated with the onset
f certain vascular ophthalmologic diseases, like central
etinal vein occlusion, arteriolar embolisms, retinal artery
cclusion and non-arteritic optic neuritis. Central retinal
ein occlusion and retinal arteriolar embolism are associated
ith increased cardiovascular mortality [43,44].
elationship with cardiovascular
orbi-mortality and cardiac and cerebral
icro- and macrovascular abnormalities
etinal microcirculation shares the same anatomic proper-
ies that the microvasculariation presents in other organs
ike the brain.
Several studies have demonstrated a relationship
etween retinopathy and the risk of nephropathy and ampu-
ation in diabetic patients regardless of other risk factors
45].
The relationship between retinal and coronary microcir-
ulation is more difﬁcult to prove. The study of an American
opulation cohort between the ages of 49 and 73 by the ARIC
17] showed that retinopathy (and not changes in arteriolar
nd venular diameters) doubled the risk of developing an
pisode of heart failure regardless of other factors. The risk
rebled in the sub-group with no history of coronary artery
isease. This association therefore prompts the idea that
icrocirculation lesions could play a role in the onset of
eart failure. In addition, a prospective study on a pop-
lation between the ages of 45 and 84 with no medical
istory (Cardiovascular Multi-Ethnic Study of Atheroscle-
osis, MESA [46]) showed that a generalised decrease in
he arteriolar diameter was associated with LV concentric
emodelling regardless of other factors. This association was
lso witnessed in the normotensive sub-group. It was not,
owever, signiﬁcant after adjustment with the presence of
etinopathy. Retinal venule dilatation only correlated with
entricular remodelling in women. The physiopathological
echanism of this association remains a little unclear. Theelationship between retinal and cardiac microcirculation
bnormalities requires further studies.
Signiﬁcant anatomical, embryological and physiological
imilarities between the cerebral and retinal microcir-
ulation were demonstrated [1]. Therefore, examining
s
T
o
a
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etinal abnormalities enables a better understanding of
he physiopathology of the cerebral microvascular changes.
ne of the prospective studies concerning an American
opulation with no history of stroke, namely the ARIC
tudy [16], showed an 11% prevalence of cerebral white
atter lesions observed by MRI. These lesions were asso-
iated independently with an increased of the risk of
troke at 5 years, speciﬁcally a RR of 3.4 (CI = [1.5—7.7]).
imilarly, the presence of retinopathy, FAN, and AVnick-
ng was associated with an increased of the risk of
troke (RR of 4) regardless of other factors. The pres-
nce of both retinopathy and cerebral white matter
esions is then associated with a stroke relative risk at
years of 18.1 (CI = [9—55.4]). The physiopathology of
hese white matter lesions is not well known. However,
t appears they are markers of cerebral microangiopathy
nd a breakdown of the blood-brain barrier. Moreover,
he retinal lesions, which have a stronger correlation with
troke risk and the presence of cerebral white matter
esions, are retinopathy lesions [47]. Thus, we can assume
hat retinal microcirculation abnormalities reﬂect cerebral
icrocirculation abnormalities and therefore the risk of
cerebrovascular disease. Similarly, several prospective
tudies involving large samples of the general population
15,18,48—50] showed that retinopathy correlated with
n increased of stroke risk cerebral infarction observed
y MRI, cerebral atrophy and a deterioration of cogni-
ive function. This correlation was weaker for the older
opulations (> 75 years). The correlation between GAN
nd the risk of stroke was not conﬁrmed in all studies
15,48,49,54,56].
The relationship between retinal microvascularisation
bnormalities, macroangiopathy disease and atherosclero-
is is less clear. Retinopathy and venular dilatation appear to
e associated with the presence of atherosclerosis markers
carotid plaques, intimal medial thickening, aortic calciﬁ-
ation and aortic and popliteal plaques [10,35]). Concerning
oronary artery disease, the MESA study [51] involving a mul-
iethnic population between the ages of 43 and 84 with no
ardiovascular history revealed a correlation between the
resence of retinopathy (and not other retinal abnormal-
ties) and coronary calciﬁcations as observed by CT scan.
n the same study, the reduced arteriolar calibre corre-
ated with a diminished myocardial perfusion reserve in
symptomatic individuals with no coronary calciﬁcations
egardless of age, gender and ethnic background [52]. On the
ther hand, other prospective studies showed that changes
n the retinal vascular caliber (and not retinopathy) were
redictive of the coronary morbidity and mortality, specif-
cally the data in the Blues Mountains Eyes Study [53,54],
RIC [55] and Cardiovascular Health Study [56]. This asso-
iation appears to be more signiﬁcant in women [55] and
hose under the age of 75. This association between reti-
al microvascularisation abnormalities and the incidence
f cardiovascular events (coronary artery disease, cardiac
nsufﬁciency and cardiovascular mortality) is more obvious
n diabetic individuals [57—59]. Nevertheless, this relation-
hip may also be secondary to a microvascular condition.
he physiopathological explanation behind the association
f retinopathy and coronary calciﬁcations on the one hand,
nd retinal vascular caliber and morbid-mortality on the
ther, is not clear.
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Conclusion
Retinal microcirculation abnormalities are widely observed
in the general population and include several lesions of
which the main ones are retinopathy, reduced arteriolar
diameter and increased venular calibre with a perceptibly
different physiopathological mechanism. The abnormalities
observed in retinopathy seem to reﬂect disorders of the
retinal vascular wall, endothelial dysfunction and inﬂam-
mation secondary to diabetes, age, hypertension, obesity
and metabolic disorders. The decreased arteriolar diameter
signals the presence of hypertension (current or old) and
the risk of hypertension onset. Current data suggest that a
genetic factor could be implicated in this relationship.
More recently, it has been revealed that an increased
venulars diameter is correlated with the presence of dia-
betes, obesity and metabolic disorders. This association
appears to be mediated partly by the presence of endothe-
lial dysfunction and inﬂammation.
The relationship of these retinal abnormalities with other
microangiopathy abnormalities has been observed mainly
in the brain and diabetic individuals. This relationship
remains more difﬁcult to highlight in the heart. The relation-
ship of macroangiopathy with retinal microvascularisation
abnormalities remains unclear. Nonetheless, the retinal vas-
cular abnormalities appear to be predictive of an increased
coronary, and more widely, cardiovascular morbidity and
mortality predominantly in individuals under the age of 75.
Markers other than the simple arteriolar diameter, which
allow a better reﬂection of the microvascular anatomic
changes such as the measurement of the wall/lumen ratio
of retinal arterioles by laser Doppler ﬂowmetry, are cur-
rently under assessment and will help further clarify these
correlations [60].
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